- Home
- HUM vs NDAQ Comparison
HUM vs NDAQ Comparison
Compare HUM & NDAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUM | NDAQ |
|---|---|---|
| Founded | 1961 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.0B | 49.1B |
| IPO Year | 2002 | 2001 |
Fundamental Metrics
Financial Performance| Metric | HUM | NDAQ |
|---|---|---|
| Price | $384.69 | $95.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 20 | 13 |
| Target Price | ★ $238.65 | $105.62 |
| AVG Volume (30 Days) | 1.2M | ★ 3.8M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.46% | 1.36% |
| EPS Growth | N/A | ★ 60.10 |
| EPS | ★ 9.83 | 1.80 |
| Revenue | ★ $129,664,000,000.00 | $4,277,000,000.00 |
| Revenue This Year | $26.15 | $10.52 |
| Revenue Next Year | $6.07 | $8.17 |
| P/E Ratio | ★ $37.33 | $52.61 |
| Revenue Growth | ★ 10.11 | 7.87 |
| 52 Week Low | $163.11 | $76.55 |
| 52 Week High | $428.88 | $101.79 |
Technical Indicators
Market Signals| Indicator | HUM | NDAQ |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 61.08 |
| Support Level | $353.06 | $84.89 |
| Resistance Level | $380.86 | $96.87 |
| Average True Range (ATR) | 15.28 | 2.11 |
| MACD | -4.50 | 0.04 |
| Stochastic Oscillator | 24.66 | 70.52 |
Price Performance
Historical ComparisonAbout HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About NDAQ Nasdaq Inc.
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.